UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $1.22M invested in Proshares UltraPro NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
1
Calls
$226K
Puts
$4K
Net Calls
+$222K
Net Calls Change
-$528K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$646K |
| 2 |
VF
Virtu Financial
New York
|
+$355K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$73K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$16.2K |
Top Sellers
| 1 |
Jane Street
New York
|
-$366K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$174K |
| 3 |
Morgan Stanley
New York
|
-$11.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $646K | +$646K | +23,346 | New |
|
|
VF
2
Virtu Financial
New York
| $355K | +$355K | +12,843 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $73K | +$73K | +2,651 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $67K | -$174K | -6,302 | -72% |
|
|
CG
5
Cutler Group
San Francisco,
California
| $47K | +$16.2K | +598 | +53% |
|
|
6
Morgan Stanley
New York
| $28K | -$11.2K | -400 | -29% |
|
|
7
Jane Street
New York
| – | -$366K | -17,347 | Closed |
|